T M Hoover - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T M Hoover

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Language and Speech|July 1, 1985

Repetition in schizophrenic speechT C Manschreck, B A Maher, T M Hoover, et al.

Psychological Medicine|February 1, 1984

The type--token ratio in schizophrenic disorders: clinical and research valueT C Manschreck, B A Maher, T M Hoover, et al.

Neurology|January 29, 2003

MRI as a biomarker of disease progression in a therapeutic trial of milameline for ADC R Jack, M Slomkowski, S Gracon, et al.

The New England Journal of Medicine|October 29, 1992

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study GroupK L Davis, L J Thal, E R Gamzu, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Language and Speech|July 1, 1985

Repetition in schizophrenic speechT C Manschreck, B A Maher, T M Hoover, et al.

Psychological Medicine|February 1, 1984

The type--token ratio in schizophrenic disorders: clinical and research valueT C Manschreck, B A Maher, T M Hoover, et al.

Neurology|January 29, 2003

MRI as a biomarker of disease progression in a therapeutic trial of milameline for ADC R Jack, M Slomkowski, S Gracon, et al.

The New England Journal of Medicine|October 29, 1992

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study GroupK L Davis, L J Thal, E R Gamzu, et al.

Pageof 1